Mary Crowley Medical Center

Dallas, Texas 75230

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Pancreatic Cancer

Studies at this site

• CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext) — Completed
• A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer — Completed